Virtual Reality in Pharma Research and Development - Brief Paper

Poster #7 ID: 55188 Type: Poster Demonstration
  1. Valerie Gamble, Pfizer Drug Safety Research and Development and i3Logic, United States
  2. Tracey Trower, Pfizer Drug Safety Research and Development, United States
  3. Catherine Reed-Voorheis, Doug Braunschweig, Tom Vasko, and Bonnie Beresford, i3Logic, Inc., United States

Tuesday, June 25 6:00 PM-7:30 PM Location: Koepelzaal View on map

Presider: Yoko Usui, Tohoku Gakuin University, Japan

Abstract: A pharma research company is piloting a training application of virtual reality (VR) technology to determine if this approach generates anticipated cost savings, improves consistency of the experience, and improves public perception of our research practices. The project goal is to determine if virtual reality training can influence the way the pharma industry looks at how training is conducted. To support this evaluation, extensive metrics are being collected to evaluate if the objectives are met. Seven virtual applications are being piloted and include a restricted laboratory tour, histology/necropsy laboratory safety and general tours, and four toxicology laboratory procedures. For this presentation, participants will be able to view a partial virtual 360 video laboratory safety tour and a restricted lab tour. Participants can learn about the steps taken by the team to secure executive team support and budget for this innovative approach and how they worked with teams to design and develop the VR applications.


Conference attendees are able to comment on papers, view the full text and slides, and attend live presentations. If you are an attendee, please login to get full access.